| |
| |
|
| Insider
Information: |
Meier Richard A |
| Relationship: |
|
| City: |
Santa Ana |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
291,160 |
|
|
Indirect Shares
|
434 |
|
|
| Direct
Value |
$20,753,649 |
|
|
|
Indirect Value
|
$89,712 |
|
|
| Total
Shares |
291,594 |
|
|
| Total
Value |
$20,843,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
1
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 -43.6%
|
 43.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-01-08 |
112,547 |
2008-07-07 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
Director |
2016-05-20 |
18,300 |
2009-08-10 |
0 |
Premium* |
|
|
Teleflex Inc |
TFX |
Exec. Vice Pres. and CFO |
2012-02-28 |
33,155 |
2012-02-28 |
434 |
Premium* |
|
|
Owens & Minor Inc |
OMI |
EVP, Chief Financial O... |
2018-02-08 |
127,158 |
2013-03-01 |
0 |
Premium* |
|
|
Intersect Ent, Inc. |
XENT |
|
2022-05-13 |
0 |
2020-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2024-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
112,547 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
115,547 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-12 |
4 |
D |
$93.93 |
$576,448 |
D/D |
(6,137) |
111,357 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-05-12 |
4 |
OE |
$67.81 |
$576,385 |
D/D |
8,500 |
117,494 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
108,994 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2022-05-13 |
4 |
D |
$28.25 |
$4,621,587 |
D/D |
(163,596) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-02 |
4 |
S |
$82.09 |
$318,345 |
D/D |
(3,878) |
104,014 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2022-05-02 |
4 |
OE |
$37.46 |
$318,410 |
D/D |
8,500 |
107,892 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2022-02-02 |
4 |
D |
$27.31 |
$63,597 |
D/D |
(2,329) |
163,596 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,738 |
165,925 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,120 |
99,392 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-06 |
4 |
S |
$78.38 |
$397,245 |
D/D |
(5,068) |
94,272 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2021-05-06 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
99,340 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,411 |
135,533 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2020-11-27 |
4 |
D |
$20.00 |
$127,003 |
D/D |
(6,349) |
118,122 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
84,340 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2020-03-17 |
4 |
B |
$7.80 |
$38,997 |
D/D |
5,000 |
124,471 |
0.01 |
- |
|
| XENT |
Intersect Ent, Inc. |
EVP & Chief Financial Officer |
• – – |
2020-03-16 |
4 |
B |
$10.19 |
$125,463 |
D/D |
10,000 |
119,471 |
0.01 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
80,040 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
86,040 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-09-13 |
4 |
S |
$99.24 |
$297,722 |
D/D |
(3,000) |
81,610 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-09-13 |
4 |
OE |
$21.51 |
$322,650 |
D/D |
15,000 |
84,610 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-08-27 |
4 |
S |
$100.12 |
$200,235 |
D/D |
(2,000) |
69,610 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-08-27 |
4 |
OE |
$14.39 |
$215,850 |
D/D |
15,000 |
71,610 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
56,610 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
